ABX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Abacus Global Management Inc (ABX) is not a strong buy at this time for a beginner investor with a long-term focus. The stock has recently experienced a significant price drop (-4.45% in regular trading and -0.11% post-market), and technical indicators like MACD and RSI suggest bearish momentum. While the company has shown strong revenue growth in Q4 2025, its net income and EPS have declined significantly, raising concerns about profitability. Additionally, analysts have downgraded the stock due to valuation concerns, and there are no strong trading signals from Intellectia Proprietary Trading Signals. For now, it is better to hold and monitor the stock for a more favorable entry point.
The MACD histogram is -0.0896, below 0, and negatively expanding, indicating bearish momentum. The RSI_6 is at 29.814, suggesting oversold conditions but no clear reversal signal. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below key support levels (S1: 9.077). Overall, technical indicators suggest bearish momentum.
Hedge funds are significantly increasing their positions in ABX, with a 182.18% increase in buying over the last quarter.
The company reported a strong revenue growth of 116.6% YoY in Q4 2025, driven by Life Solutions and asset management fees.
Strategic acquisition of a minority equity stake in Manning & Napier for $53 million, indicating growth initiatives in wealth management.
The stock price has dropped significantly (-4.45% in regular trading and -0.11% post-market).
Analysts have downgraded the stock due to valuation concerns, with Piper Sandler moving it to Neutral from Overweight.
Financial performance shows a sharp decline in net income (-300.06% YoY) and EPS (-254.55% YoY) in Q4 2025, raising concerns about profitability.
No recent congress trading data or influential figure activity to indicate confidence in the stock.
In Q4 2025, Abacus Global Management reported revenue growth of 116.6% YoY to $71.9M. However, net income dropped by -300.06% YoY, and EPS fell by -254.55% YoY, indicating significant profitability challenges. Gross margin remained relatively stable, dropping slightly by -0.04% YoY to 80.54.
Piper Sandler downgraded the stock to Neutral from Overweight with an $11 price target, citing valuation concerns after a 100% price increase since mid-2025. This downgrade is not due to poor company performance but rather reflects the view that the stock's value has already been realized.
